Literature DB >> 2747138

[Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].

U Hay1, A Sedlmayer, M M Müller, W Dorda, G Schernthaner.   

Abstract

For some years the glycosylated plasma proteins, the so-called fructosamines, have been used for the evaluation of metabolic control in diabetic patients. We studied the usefulness of fructosamine as an intermediate parameter in the control of diabetes and we also corrected fructosamine for serum protein. Furthermore, the dependence on daily times and amounts of food intake were examined for fructosamine alone as well as for protein-corrected fructosamine. Both parameters showed a statistically significant correlation with HbA1C (r = 0.7; P less than 0.001). Changes in the metabolic state of the diabetic patients were reflected more rapidly by both these parameters than by HbA1C. While the correction of fructosamine for serum protein eliminated its postprandial increase in the diabetic patients, circadian variation remained unchanged.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2747138     DOI: 10.1007/bf01711265

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  11 in total

1.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

2.  [Glycohemoglobin (HbA1): a valuable parameter for the evaluation of long-term control of diabetes].

Authors:  G Schernthaner
Journal:  Dtsch Med Wochenschr       Date:  1982-07-16       Impact factor: 0.628

3.  Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.

Authors:  J R Baker; R N Johnson; D J Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

4.  Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus.

Authors:  J R Baker; J P O'Connor; P A Metcalf; M R Lawson; R N Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

5.  The estimation of serum fructosamine: an alternative measurement to glycated haemoglobin.

Authors:  E J Hindle; G M Rostron; J A Gatt
Journal:  Ann Clin Biochem       Date:  1985-01       Impact factor: 2.057

6.  Intra-individual variation of some analytes in serum of patients with insulin-dependent diabetes mellitus.

Authors:  W G Hölzel
Journal:  Clin Chem       Date:  1987-01       Impact factor: 8.327

7.  Measurement of plasma fructosamine evaluated for monitoring diabetes.

Authors:  Y S Lim; M J Staley
Journal:  Clin Chem       Date:  1985-05       Impact factor: 8.327

8.  Haemoglobin A1: An indicator of the metabolic control of diabetic patients.

Authors:  B Gonen; A Rubenstein; H Rochman; S P Tanega; D L Horwitz
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

9.  Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus.

Authors:  J R Baker; P A Metcalf; I M Holdaway; R N Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02

10.  Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus.

Authors:  K H Gabbay; K Hasty; J L Breslow; R C Ellison; H F Bunn; P M Gallop
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

View more
  1 in total

1.  [Critical evaluation of fructosamine as a control parameter in the assessing diabetic metabolic control].

Authors:  J Windeler
Journal:  Klin Wochenschr       Date:  1989-10-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.